AU

George Gabor Miklos

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Gabor Miklos. Retrieved from https://idiyas.com/inventor/george-gabor-miklos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: George Gabor Miklos: Innovator in Microbial Nucleic Acid Simplification

Introduction

George Gabor Miklos is an accomplished inventor based in Australia. He has made significant contributions to the field of microbial genetics. His innovative methods focus on simplifying microbial nucleic acids, which can have profound implications for genetic research and biotechnology.

Latest Patents

Miklos holds a patent titled "Methods For Simplifying Microbial Nucleic Acids By Chemical Modification Of Cytosines." This method involves treating microbial genomes or nucleic acids with an agent that modifies cytosine. The process results in the formation of derivative microbial nucleic acids, which can then be amplified to produce a simplified form of the microbial genome or nucleic acid. Although he has 0 patents, this particular method showcases his expertise in the field.

Career Highlights

George Gabor Miklos is associated with Human Genetic Signatures Pty. Ltd., where he applies his knowledge and skills in microbial genetics. His work contributes to advancements in genetic testing and diagnostics. His innovative approach to simplifying microbial nucleic acids is a testament to his dedication to the field.

Collaborations

Miklos collaborates with Douglas Spencer Millar, a fellow professional in the field. Their partnership enhances the research and development efforts at Human Genetic Signatures Pty. Ltd. Together, they work towards advancing the understanding of microbial genetics.

Conclusion

George Gabor Miklos is a notable inventor whose work in microbial nucleic acid simplification is paving the way for future innovations in genetic research. His contributions are essential for the ongoing advancements in biotechnology and genetics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…